So-Young International Inc
NASDAQ:SY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
So-Young International Inc
NASDAQ:SY
|
CN |
|
RaffAello-Astrum Financial Holdings Ltd
HKEX:8333
|
HK |
|
Accuray Inc
NASDAQ:ARAY
|
US |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
CN |
|
Yunnan Chihong Zinc & Germanium Co Ltd
SSE:600497
|
CN |
|
Pinnacle West Capital Corp
NYSE:PNW
|
US |
|
Thinkingdom Media Group Ltd
SSE:603096
|
CN |
|
S
|
Sirius XM Holdings Inc
XETRA:RDO
|
US |
|
Byke Hospitality Ltd
NSE:BYKE
|
IN |
|
D
|
Dollarama Inc
OTC:DLMAF
|
CA |
|
H
|
Heineken Holding NV
OTC:HKHHF
|
NL |
|
S
|
Suzhou Jinhongshun Auto Parts Co Ltd
SSE:603922
|
CN |
|
Q
|
Qingdao Kutesmart Co Ltd
SZSE:300840
|
CN |
|
Elanor Commercial Property Fund
ASX:ECF
|
AU |
So-Young International Inc
So-Young International, Inc. engages in discovering, evaluating and reserving medical aesthetic services. The company is headquartered in Beijing, Beijing. The company went IPO on 2019-05-02. The firm operates through two segments: Information Services segment and Reservation Services segment.
So-Young International, Inc. engages in discovering, evaluating and reserving medical aesthetic services. The company is headquartered in Beijing, Beijing. The company went IPO on 2019-05-02. The firm operates through two segments: Information Services segment and Reservation Services segment.
Revenue: Total Q4 revenue RMB 460.7 million, a record quarter and up 24.8% YoY; aesthetic center revenue RMB 248.1 million, up 205.3% YoY and ~10% above the high end of guidance.
Scale: So‑Young operated 49 clinics at year‑end (largest by center count nationwide); Q4 verified treatment visits exceeded 125,000 and verified procedures exceeded 289,400; active users surpassed 170,000.
Profitability progress: 25 centers were profitable and 39 centers generated positive operating cash flow in Q4; management plans to shift in 2026 from “scale first” to balancing scale with efficiency.
Cash & runway: Cash, restricted cash, term deposits and short‑term investments totaled RMB 936.4 million as of Dec 31, 2025 (down from RMB 1,253.2 million a year earlier due to center investment).
Losses narrowed: Net loss attributable to So‑Young was RMB 108.8 million in Q4 (improved from RMB 607.6 million a year ago); non‑GAAP net loss RMB 93.4 million; basic/diluted loss per ADS RMB 1.08.
Guidance & 2026 plan: Q4 2026 aesthetic treatment revenue guidance RMB 268–278 million (implies YoY growth of 171.2%–181.3%); company plans to open no fewer than 35 new centers in 2026.
Key investor questions: Analysts pressed management on gross margin expansion levers, performance in second‑tier cities, CAC sustainability and core member LTV improvements.
